<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: Heat shock proteins (<z:chebi fb="24" ids="50430">HSPs</z:chebi>) are important regulators of cellular survival and exert neuroprotective effects against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Both <z:chebi fb="0" ids="15544">prostaglandin E1</z:chebi> (<z:chebi fb="0" ids="15544">PGE1</z:chebi>) and <z:chebi fb="32" ids="30145">lithium</z:chebi> have been reported to protect neurons against ischemic injury </plain></SENT>
<SENT sid="2" pm="."><plain>The present study was undertaken to examine if <z:chebi fb="32" ids="30145">lithium</z:chebi> could potentiate the neuroprotection of <z:chebi fb="0" ids="15544">PGE1</z:chebi> against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, and if the synergetic effects take place at the level of <z:chebi fb="24" ids="50430">HSPs</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">Brain ischemia</z:e> was induced by a permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (pMCAO) in rats </plain></SENT>
<SENT sid="4" pm="."><plain>Rats were pretreated with subcutaneous injection of <z:chebi fb="32" ids="30145">lithium</z:chebi> for 2 d and a single intravenous administration of <z:chebi fb="0" ids="15544">PGE1</z:chebi> immediately after ischemic insult </plain></SENT>
<SENT sid="5" pm="."><plain>Cerebrocortical blood flow of each group was closely monitored prior to <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, 5 min, 15 min, 30 min and 60 min after surgical operation </plain></SENT>
<SENT sid="6" pm="."><plain>Body temperature was measured before, 5 min, 2 h and 24 h after the <z:hpo ids='HP_0003674'>onset</z:hpo> of pMCAO </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, <z:hpo ids='HP_0002181'>brain edema</z:hpo> and motor behavior deficits were analyzed 24 h after ischemic insult </plain></SENT>
<SENT sid="8" pm="."><plain>Cytoprotective HSP70 and <z:chebi fb="4" ids="30413">heme</z:chebi> oxygenase-1 (HO-1) in the striatum of the ipsilateral hemisphere were detected by immunoblotting </plain></SENT>
<SENT sid="9" pm="."><plain>Brain sections from the striatum of the ipsilateral hemisphere were double-labeled with the anti-HSP70 antibody and 4,6-diamidino-2-<z:chebi fb="0" ids="48559">phenylindole</z:chebi> (<z:chebi fb="0" ids="51231">DAPI</z:chebi>) </plain></SENT>
<SENT sid="10" pm="."><plain>RESULTS: Treatment with <z:chebi fb="0" ids="15544">PGE1</z:chebi> (8 and 16 microg/kg, iv) or <z:chebi fb="32" ids="30145">lithium</z:chebi> (0.5 mEq/kg, sc) alone reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, neurological deficits and <z:hpo ids='HP_0002181'>brain edema</z:hpo> induced by focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats </plain></SENT>
<SENT sid="11" pm="."><plain>Moreover, a greater neuroprotection was observed when <z:chebi fb="0" ids="15544">PGE1</z:chebi> and <z:chebi fb="32" ids="30145">lithium</z:chebi> were given together </plain></SENT>
<SENT sid="12" pm="."><plain>Co-administration of <z:chebi fb="0" ids="15544">PGE1</z:chebi> and <z:chebi fb="32" ids="30145">lithium</z:chebi> significantly upregulated cytoprotective HSP70 and HO-1 protein levels </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSION: <z:chebi fb="32" ids="30145">Lithium</z:chebi> and <z:chebi fb="0" ids="15544">PGE1</z:chebi> may exert synergistic effects in treatment of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and thus may have potential clinical value for the treatment of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>